Asensus Surgical (NYSE:ASXC) shares slid today on fourth-quarter results that missed the consensus sales forecast. The Research Triangle Park, North Carolina-based surgical robotics company posted losses of $15.9 million, or 7¢ per share, on sales of $2.1 million for the three months ended Dec. 31, 2021, for a slight bottom-line further into the red despite […]
Asensus Surgical
Russian hospital initiates program with Asensus Surigical’s Senhance surgical robot
Asensus Surgical (NYSE:ASXC) announced today that a private Russian healthcare institution began a program with its Senhance system. Research Triangle Park, North Carolina-based Asensus said in a news release that the Railway Clinical Hospital RZD Medicine of Rostov-on-Don (RZD Medicine) purchased a Senhance surgical robotic system. RZD Medicine has initiated a robotic surgery program with […]
Asensus Surgical ticks up on Street-beating Q3 revenues
Asensus Surgical (NYSE:ASXC) shares rose today on third-quarter results that topped the consensus sales forecast. ASXC shares were up 10.3% at $2.04 in after-hours trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.1%. Headquartered in North Carolina’s Research Triangle Park, the robotic […]
Asensus Surgical’s board chair is leaving
Asensus Surgical (NYSE:ASXC) announced that Paul LaViolette, the company’s board chair, will step down from his position. LaViolette, who has served as the chair of the board since 2013, will step down as chair later this month and intends to leave the board before the end of the year due to other professional commitments. According […]
FDA clears expanded machine vision capabilities for Asensus Surgical’s robotic surgery system
Asensus Surgical (NYSE American: ASXC) announced today that FDA has cleared next-gen augmented intelligence capabilities on its Senhance system’s Intelligent Surgical Unit. The ISU already enabled machine vision-driven camera control; the system responded to the surgeon’s commands and even recognized certain objects and locations in the surgical field. The new ISU features expand the capabilities […]
MedTech 100 roundup: Industry ticks up again
The medtech industry has been rising for weeks and the latest seven-day stretch was no exception as stocks ticked up again. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 6) at 119.41 points, marking a 0.5% rise from the previous week’s tally of 118.86 […]
Asensus Surgical reports mixed Q2 results
Asensus Surgical (NYSE American: ASXC) reported second-quarter results that beat the Wall Street earnings consensus forecast but missed on revenue. The Research Triangle Park, N.C.–based surgical robotics company reported a loss of –$13.2 million, or –6¢ per common share, off revenue of $1.1 million for the quarter ended June 30, 2021 — versus a loss […]
FDA clears articulating instruments for Asensus Surgical’s robotic system
Asensus Surgical (NYSE American: ASXC) announced today that FDA has cleared 5 mm diameter articulating instruments for the company’s Senhance surgical system. The instruments previously received a CE mark in the EU. They provide better access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom. “Bringing the benefits of 5 mm […]
Swiss hospital to begin program with Asensus’ Senhance robotic surgical system
Asensus Surgical (NYSE:ASXC) announced today that a Swiss hospital initiated a program with the Senhance robotic surgical system. Inselspital, University Hospital Bern, Switzerland initiated its Senhance surgical system program, marking the second of two new agreements with two European hospitals in 2021, according to a news release. The university’s department of visceral surgery is implementing […]
Asensus Surgical posts Q1 earnings beat
Asensus Surgical (NYSE:ASXC) shares are down today — a day after the company posted Q1 results that edged the consensus earnings forecast. The Research Triangle Park, N.C.-based robotic surgery company — formerly known as TransEnterix — posted losses of -$17.3 million, or -8¢ per share, on sales of $2.1 million for the three months ended […]
MedTech 100 roundup: Industry rebounds from massive dip
The medtech industry saw its largest fall in several months last week, but it has rebounded slightly after a couple of bad weeks. A strong start to 2021 hit a skid at the end of February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It had […]
